Friday, August 1, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

Money Compass by Money Compass
July 30, 2025
in PR Newswire
0
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

SINGAPORE, July 30, 2025 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition. Mary Gunn has stepped down effective immediately. The Board has appointed Glenn Kerkhof, a long-standing Board member and experienced CRO executive, as Interim CEO.

Emerald Clinical Trials

The Board has commenced a formal search for a permanent CEO and has asked Glenn Kerkhof to lead the organization through this period to ensure continuity, stability and strong execution.

Related posts

SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today

SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today

August 1, 2025
SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today

SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today

August 1, 2025

“We thank Mary for her contributions,” said Sean Carney, Chair of the Board. “Emerald Clinical Trials is a leading CRO with global capabilities and with Glenn stepping in as Interim CEO, we are confident in our ability to maintain momentum and deliver for our clients,” Sean Carney said.

Glenn Kerkhof brings more than 30 years of executive experience in clinical research and pharmaceutical services. Glenn was previously CEO of Chiltern, where he led the company through major international expansion, and served as Executive Chairman of George Clinical (now Emerald Clinical Trials), helping shape its growth across Asia.

“Emerald Clinical’s strengths lie in our therapeutic focus, scientific depth and close client partnerships,” said Glenn Kerkhof. “I am focused on a smooth transition, strong delivery for customers, and supporting our global teams. I am committed to building on our momentum and leading with clarity and purpose,” he said.

About Emerald Clinical Trials
Emerald Clinical Trials is a leading clinical research organization operating worldwide that serves over 100 biotechs, and 6 of the top 10 pharmaceutical companies. Headquartered in Singapore and driven by operational expertise and scientific excellence, the company provides comprehensive clinical trial services to clients globally, offering solutions across all trial phases. For more information, visit www.emeraldclinical.com.

Cision View original content:https://www.prnewswire.com/apac/news-releases/emerald-clinical-trials-confirms-ceo-transition-and-continuity-plan-302517344.html

SOURCE Emerald Clinical Trials

​ 

Previous Post

Patriot Battery Metals Announces Board Changes

Next Post

CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System

Next Post
CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System

CLO Unveils the zFab Kit: a Revolutionary AI-Powered Fabric Digitization System

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today
  • SIEW 2025 Registration Opens: Envisioning Energy Tomorrow, Building Systems Today
  • DermRays Elevates Upgraded Revive & Debuts World’s First Men’s At-Home Hair Removal Diode Laser Device, V10S

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved